Compare LITB & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LITB | SCNX |
|---|---|---|
| Founded | 2007 | 2010 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Other Pharmaceuticals |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.1M | 16.2M |
| IPO Year | 2013 | 2019 |
| Metric | LITB | SCNX |
|---|---|---|
| Price | $3.04 | $0.31 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.50 |
| AVG Volume (30 Days) | 5.6K | ★ 294.3K |
| Earning Date | 05-12-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,831,778.00 |
| Revenue This Year | $14.50 | $1,097.38 |
| Revenue Next Year | $11.59 | $239.80 |
| P/E Ratio | $10.96 | ★ N/A |
| Revenue Growth | N/A | ★ 30.72 |
| 52 Week Low | $1.63 | $0.24 |
| 52 Week High | $4.17 | $2.60 |
| Indicator | LITB | SCNX |
|---|---|---|
| Relative Strength Index (RSI) | 44.52 | 31.79 |
| Support Level | $2.82 | $0.30 |
| Resistance Level | $2.97 | $0.43 |
| Average True Range (ATR) | 0.13 | 0.02 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 3.39 | 10.60 |
LightInTheBox Holding Co Ltd is a e-commerce company, providing a diverse range of affordable lifestyle products directly to consumers. Its brands include Ador, a women's fashion brand targeting women aged 35-55; the second is a golf apparel brand focusing on female golfers aged 35 and above; the third is a women's light party dress brand for the age group of 30 and above. It offers customers products through websites and mobile applications. The company operates and reviews its performance in two segments: Product sales which consisted of online retailing of consumer products and sales to third-party sellers, and Services which consisted of the provision of logistic services to companies and individual customers.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.